WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'4101 Infant (under 12 months) mortality rate: 292
GDP / capita (US$): 3'3991 Child (under 5 years) mortality rate: 362

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 795  791  786  781  776  744  725  777 
Births 16  17  17  17  17  16  17  23 
Surviving infants 16  16  16  17  17  16  16  21 
Pop. less than 5 years 89  93  98  99  96  87  85  119 
Pop. less than 15 years 292  294  295  291  286  263  250  330 
Female 15-49 years 202  201  200  199  199  193  198  185 

Number of reported case

(Click for retrospective incidence data for Guyana)
Diphtheria
Japanese encephalitis
Measles 464 
Mumps
Pertussis 61 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal) 1'010 
Tetanus (total) 1'010  20 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Guyana)
Vaccine year result method % card seen                                                
BCG 2007  94  DHS   87.7  98  97  98  98  96  93  85  68 
DTP1 2007  92  DHS   87.7  99  92  100  97  94  97 
DTP3 2007  85  DHS   87.7  97  93  95  98  93  88  82  36 
HepB_BD         
HepB3 2007  85  DHS   87.7  97  93  95  98  93 
Hib3 2007  85  DHS   87.7  97  93  95  98  93 
JapEnc         
MCV 2007  82  DHS   87.7  99  98  95  97  95  86  73 
MCV2          90  84  82  84  84 
PCV1          94  78 
PCV3          90  50 
Pol3 2007  70  DHS   87.7  97  93  95  97  93  79  79  42 
Rota1          95  82  70 
Rota_last          91  77  38 
Rubella1          99  98  95  97  95 
TT2plus 1999  61  MICS   88.7  95  97  97  97  94  81 
PAB         
VAD1         
YFV 2007  79  DHS   87.7  99  97  95  97  97  83 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Guyana)
BCG 98  97  98  98  96  93  85  68 
DTP1 99  97  99  99  94  97  94  60 
DTP3 97  93  95  98  93  88  83  35 
HepB3 97  93  95  98  93 
Hib3 97  93  95  98  93 
MCV 99  98  95  97  95  86  73 
PAB 90  90  97  90  90  82  56 
PCV3 90  50 
Pol3 97  93  95  97  93  79  79  42 
Rota_last 91  77  39 
YFV 99  97  94  97  97  83 

Number of districts in the country 13  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 77
From 80 to 89% 15
From 50 to 79% 8
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 2 months; Yes
DTwPHibHep 2, 4, 6 months; Yes
HIB 2, 4, 6 months; Yes
HPV 1st contact; +1, +6 months; No
HepB +1, +5 months; Yes adults
IPV 2, 4, 6, 18 months; 3 years; No special groups
MMR 12 months; 3 years and 9 months; Yes
MenACW special groups
OPV 2, 4, 6, 19 months; 3 years; Yes
Pneumo_conj 2, 4, 6 months; Yes
Rotavirus 2, 4, 6 months; Yes
Td 15 years; Yes
YF 12 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2006-2015  2006-2015  2008-2015  2007-2012  2007-2012  2007-2012   
Nº of districts with microplans that include activities to raise immunization coverage number 13  13  13  13  13  13  13 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  No         

System performance

Total number of districts in country number 13  13  13  13  13  13  13 
Nº districts with DTP3 coverage >=80% number 12  12    13  13  13  12 
% of districts with DTP3 coverage >=80% From 0 to 100% 92  92    100  100  100  92 
Nº districts with measles (MCV1) coverage >=95% number      
% of districts with MCV1 coverage >=95% From 0 to 100% 69  62    62  62     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 57  54  100  100  97  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.